Australian Cardiovascular AllianceCardiovascular research benefiting all Australians
The Australian Cardiovascular Alliance (ACvA) is the peak leadership body in the country for the advancement of heart, stroke and vascular disease research.
It is a comprehensive collaboration of the very highest quality cardiovascular research bodies and scientific societies, individual researchers, industry and non-government organisations in Australia and is uniquely positioned to leverage key interactions between Australia’s strong research capability and the health system to improve health outcomes and reduce costs.
A Snapshot of Australia’s Cardiovascular Health
1 in 3 deaths in Australia are from CV disease, killing one Australian every 12 minutes.
At $8.8 Billion annually, CV disease is Australia’s largest direct health care cost.
Atherosclerosis is the major cause of heart attack and peripheral vascular disease, and contributes substantially to stroke and renal failure. It explains 75% of CV deaths every 12 minutes.
Heart failure will affect 20% of adults in their lifetime.
56,000 strokes in Australia in 2017; 65% of survivors are unable to carry out daily living activities unassisted.
One Australian limb amputated every
2 hours due to complications of peripheral arterial disease and diabetes.
1.1 million hospitalisation for CV in 2015-16, accounting for 11% of all hospitalisation.
CV disease disproportionately affects indigenous, remote and socioeconomically disadvantaged Australians.
The ACvA institutes and societies bring expertise that spans fundamental biomedical research through to global clinical trial and public health bodies.
We work in partnership with the Heart Foundation, and industry members committed to the improvement of cardiovascular health in Australia. We are deeply engaged with the NH&MRC-recognised Australian Health and Research Translational Centres and extend into primary care, which is essential for health impact.
As a member-driven organisation, the ACvA believes the time is ripe for a new vision, new thinking and new strategies to solve cardiovascular disease.
We have developed a strong case for investment in cardiovascular health that represents a step change for cardiovascular health, bringing together our entire cardiovascular research community and promoting a whole-of-nation approach along a bi-directional translational pipeline. This will ensure that our talented researchers are aligned to the most urgent clinical challenges and that discoveries and innovative approaches to care are translated to the bedside in an accelerated manner. These ambitious objectives can only be met through significant investment, leadership and collaboration.
ACvA Latest News
We have some exciting news from our new Executive Director, Kerry Doyle. Click HERE to download the newsletter and read on about Kerry's plans for the year and the Mission.Membership renewals for 2020 are now open, please log in here, to renew your membership by 31...read more
HOT OFF THE PRESSHappy 2020 to all our members.We have exciting news……Many of you are aware that we have run a highly competitive recruitment process for the critical leadership position in our team- our inaugural Executive Director.The Executive Director is the key...read more
ACvA e newsletter is now available .....read on to see all the terrific progress that has been made to date Click the image to read more and download the newsletterread more